Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_assertion type Assertion NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_head.
- NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_assertion description "[Our study showed that PIK3CA mutations are associated with a good prognosis in patients with MSS stage I-III CC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_provenance.
- NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_assertion evidence source_evidence_literature NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_provenance.
- NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_assertion SIO_000772 25641861 NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_provenance.
- NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_assertion wasDerivedFrom befree-2016 NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_provenance.
- NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_assertion wasGeneratedBy ECO_0000203 NP1260153.RAcj4EPXYF8mI7io1vLG_yEgENHDFUd-k-YoQJNb-g2Vg130_provenance.